vs
Kimbell Royalty Partners, LP（KRP）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
Kimbell Royalty Partners, LP的季度营收约是RIGEL PHARMACEUTICALS INC的1.2倍（$82.5M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 30.1%，领先354.0%），Kimbell Royalty Partners, LP同比增速更快（23.6% vs 21.2%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 0.1%）
Kimbell Royalty Partners, LP是一家美国上市有限合伙企业，主营油气矿产及特许权权益的持有与收购，资产覆盖二叠纪、巴肯、伊格尔福特等美国核心陆上产油盆地，收入来源于对应资产开采的特许权使用费。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
KRP vs RIGL — 直观对比
营收规模更大
KRP
是对方的1.2倍
$69.8M
营收增速更快
KRP
高出2.4%
21.2%
净利率更高
RIGL
高出354.0%
30.1%
两年增速更快
RIGL
近两年复合增速
0.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $82.5M | $69.8M |
| 净利润 | $24.8M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 39.6% | 33.2% |
| 净利率 | 30.1% | 384.0% |
| 营收同比 | 23.6% | 21.2% |
| 净利润同比 | 163.2% | 1769.2% |
| 每股收益（稀释后） | — | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KRPRIGL
| Q4 25 | $82.5M | $69.8M | ||
| Q3 25 | $80.6M | $69.5M | ||
| Q2 25 | $86.5M | $101.7M | ||
| Q1 25 | $84.2M | $53.3M | ||
| Q4 24 | $66.7M | $57.6M | ||
| Q3 24 | $83.8M | $55.3M | ||
| Q2 24 | $76.6M | $36.8M | ||
| Q1 24 | $82.2M | $29.5M |
净利润KRPRIGL
| Q4 25 | $24.8M | $268.1M | ||
| Q3 25 | $22.3M | $27.9M | ||
| Q2 25 | $26.7M | $59.6M | ||
| Q1 25 | $25.9M | $11.4M | ||
| Q4 24 | $-39.3M | $14.3M | ||
| Q3 24 | $25.8M | $12.4M | ||
| Q2 24 | $15.2M | $-1.0M | ||
| Q1 24 | $9.3M | $-8.2M |
毛利率KRPRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率KRPRIGL
| Q4 25 | 39.6% | 33.2% | ||
| Q3 25 | 35.8% | 40.9% | ||
| Q2 25 | 43.7% | 60.1% | ||
| Q1 25 | 39.9% | 23.9% | ||
| Q4 24 | -58.0% | 28.9% | ||
| Q3 24 | 40.8% | 25.4% | ||
| Q2 24 | 31.2% | 1.2% | ||
| Q1 24 | 21.4% | -23.6% |
净利率KRPRIGL
| Q4 25 | 30.1% | 384.0% | ||
| Q3 25 | 27.7% | 40.2% | ||
| Q2 25 | 30.8% | 58.6% | ||
| Q1 25 | 30.7% | 21.5% | ||
| Q4 24 | -58.8% | 24.9% | ||
| Q3 24 | 30.8% | 22.5% | ||
| Q2 24 | 19.8% | -2.8% | ||
| Q1 24 | 11.4% | -27.9% |
每股收益（稀释后）KRPRIGL
| Q4 25 | — | $14.11 | ||
| Q3 25 | — | $1.46 | ||
| Q2 25 | — | $3.28 | ||
| Q1 25 | — | $0.63 | ||
| Q4 24 | — | $0.82 | ||
| Q3 24 | — | $0.70 | ||
| Q2 24 | — | $-0.06 | ||
| Q1 24 | — | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $44.0M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | — | $391.5M |
| 总资产 | $1.2B | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资KRPRIGL
| Q4 25 | $44.0M | $155.0M | ||
| Q3 25 | $40.0M | $137.1M | ||
| Q2 25 | $34.5M | $108.4M | ||
| Q1 25 | $35.6M | $77.1M | ||
| Q4 24 | $34.2M | $77.3M | ||
| Q3 24 | $34.7M | $61.1M | ||
| Q2 24 | $30.9M | $49.1M | ||
| Q1 24 | $39.7M | $49.5M |
总债务KRPRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益KRPRIGL
| Q4 25 | — | $391.5M | ||
| Q3 25 | — | $117.6M | ||
| Q2 25 | — | $81.9M | ||
| Q1 25 | — | $18.6M | ||
| Q4 24 | — | $3.3M | ||
| Q3 24 | — | $-14.6M | ||
| Q2 24 | — | $-29.9M | ||
| Q1 24 | — | $-31.7M |
总资产KRPRIGL
| Q4 25 | $1.2B | $513.6M | ||
| Q3 25 | $1.3B | $242.5M | ||
| Q2 25 | $1.3B | $206.7M | ||
| Q1 25 | $1.3B | $176.0M | ||
| Q4 24 | $1.1B | $164.0M | ||
| Q3 24 | $1.2B | $139.4M | ||
| Q2 24 | $1.2B | $128.4M | ||
| Q1 24 | $1.3B | $126.5M |
负债/权益比KRPRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $57.2M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 2.31× | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流KRPRIGL
| Q4 25 | $57.2M | $22.0M | ||
| Q3 25 | $62.8M | $24.0M | ||
| Q2 25 | $72.3M | $30.5M | ||
| Q1 25 | $54.2M | $-893.0K | ||
| Q4 24 | $56.6M | $14.5M | ||
| Q3 24 | $62.4M | $21.7M | ||
| Q2 24 | $62.9M | $302.0K | ||
| Q1 24 | $69.0M | $-5.0M |
现金转化率KRPRIGL
| Q4 25 | 2.31× | 0.08× | ||
| Q3 25 | 2.81× | 0.86× | ||
| Q2 25 | 2.71× | 0.51× | ||
| Q1 25 | 2.09× | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | 2.42× | 1.75× | ||
| Q2 24 | 4.14× | — | ||
| Q1 24 | 7.39× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KRP
| Oil And Condensate | $45.9M | 56% |
| Natural Gas Midstream | $19.5M | 24% |
| NGL Revenue | $10.6M | 13% |
| Other | $6.4M | 8% |
RIGL
暂无分部数据
